GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iZafe Group AB (OSTO:IZAFE B) » Definitions » Capex-to-Operating-Income

iZafe Group AB (OSTO:IZAFE B) Capex-to-Operating-Income : 0.00 (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is iZafe Group AB Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

iZafe Group AB's Capital Expenditure for the three months ended in Dec. 2024 was kr0.00 Mil. Its Operating Income for the three months ended in Dec. 2024 was kr-5.70 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


iZafe Group AB Capex-to-Operating-Income Historical Data

The historical data trend for iZafe Group AB's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iZafe Group AB Capex-to-Operating-Income Chart

iZafe Group AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

iZafe Group AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of iZafe Group AB's Capex-to-Operating-Income

For the Medical Instruments & Supplies subindustry, iZafe Group AB's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iZafe Group AB's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iZafe Group AB's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where iZafe Group AB's Capex-to-Operating-Income falls into.



iZafe Group AB Capex-to-Operating-Income Calculation

iZafe Group AB's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -19.425
=N/A

iZafe Group AB's Capex-to-Operating-Income for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / -5.697
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iZafe Group AB  (OSTO:IZAFE B) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


iZafe Group AB Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of iZafe Group AB's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


iZafe Group AB Business Description

Traded in Other Exchanges
Address
David Bagares Gata 3, Stockholm, SWE, 111 38
iZafe Group AB is a pure Life-Science company engaged in the development of digital drug dispensing. The company conducts research, development and marketing of digital medical solutions and services for safer drug management at home. iZafe's drug robot Dosell is used to reduce the risk of incorrect medication at home, relieve public care, increase the patient's quality of life and create a safer environment for relatives. The customers consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe sells through well-established partners who already have long and deep customer relationships with the priority customer groups.

iZafe Group AB Headlines

No Headlines